{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3612, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de075-e29f-7298-83f4-f399e710dc49", "docSlug": "23480e67a083cbde563694d24fd9cdc8", "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides", "authorId": "akt-pictures", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "team_bio", "function": "other", "notes": "This is a character bio slide for a film or series pitch.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/6", "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49", "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 11, "from": 6, "beatId": "ee4f824f-4bd2-4257-9a0d-4ac6023cc1d2", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Call to Adventure", "beatSlug": "heros-journey-call-to-adventure", "evidence": "The team bios could be seen as assembling the team for the adventure.", "position": 2, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e29f-7298-83f4-f399e710dc49", "docSlug": "23480e67a083cbde563694d24fd9cdc8", "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides", "authorId": "akt-pictures", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "team_bio", "function": "other", "notes": "The slide presents a character archetype, likely for a film or creative project pitch.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/7", "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49", "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 11, "from": 6, "beatId": "ee4f824f-4bd2-4257-9a0d-4ac6023cc1d2", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Call to Adventure", "beatSlug": "heros-journey-call-to-adventure", "evidence": "The team bios could be seen as assembling the team for the adventure.", "position": 2, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e29f-7298-83f4-f399e710dc49", "docSlug": "23480e67a083cbde563694d24fd9cdc8", "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides", "authorId": "akt-pictures", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "team_bio", "function": "other", "notes": "Slide describes a fictional character and the actress portraying her.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/8", "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49", "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 11, "from": 6, "beatId": "ee4f824f-4bd2-4257-9a0d-4ac6023cc1d2", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Call to Adventure", "beatSlug": "heros-journey-call-to-adventure", "evidence": "The team bios could be seen as assembling the team for the adventure.", "position": 2, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e29f-7298-83f4-f399e710dc49", "docSlug": "23480e67a083cbde563694d24fd9cdc8", "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides", "authorId": "akt-pictures", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "team_bio", "function": "other", "notes": "The slide introduces a character named Mr. Endo, played by Ken'ichi Endo, describing his role as the owner of DoggieMart.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/9", "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49", "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 11, "from": 6, "beatId": "ee4f824f-4bd2-4257-9a0d-4ac6023cc1d2", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Call to Adventure", "beatSlug": "heros-journey-call-to-adventure", "evidence": "The team bios could be seen as assembling the team for the adventure.", "position": 2, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e29f-7298-83f4-f399e710dc49", "docSlug": "23480e67a083cbde563694d24fd9cdc8", "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides", "authorId": "akt-pictures", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "team_bio", "function": "other", "notes": "The slide presents character bios for a film or project, featuring headshots and scene stills.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/10", "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49", "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 11, "from": 6, "beatId": "ee4f824f-4bd2-4257-9a0d-4ac6023cc1d2", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Call to Adventure", "beatSlug": "heros-journey-call-to-adventure", "evidence": "The team bios could be seen as assembling the team for the adventure.", "position": 2, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e29f-7298-83f4-f399e710dc49", "docSlug": "23480e67a083cbde563694d24fd9cdc8", "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides", "authorId": "akt-pictures", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "team_bio", "function": "other", "notes": "The slide is split into two distinct sections: a character bio for Jared (played by Adam Hagenbuch) and a visual collage of celebrity animals.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/11", "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49", "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 11, "from": 6, "beatId": "ee4f824f-4bd2-4257-9a0d-4ac6023cc1d2", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Call to Adventure", "beatSlug": "heros-journey-call-to-adventure", "evidence": "The team bios could be seen as assembling the team for the adventure.", "position": 2, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e29f-7298-83f4-f399e710dc49", "docSlug": "23480e67a083cbde563694d24fd9cdc8", "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides", "authorId": "akt-pictures", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "other", "function": "establish_context", "notes": "Uses paw print icons as bullet points.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/12", "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49", "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 12, "beatId": "a7c7c48d-6147-4b5b-a88f-84cd050dfa91", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "Narrative styles and successful movies in related genres highlight the need for their project.", "position": 3, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e29f-7298-83f4-f399e710dc49", "docSlug": "23480e67a083cbde563694d24fd9cdc8", "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides", "authorId": "akt-pictures", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "other", "function": "establish_context", "notes": "The slide uses a comparative approach to validate the commercial viability of specific tropes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/13", "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49", "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 12, "beatId": "a7c7c48d-6147-4b5b-a88f-84cd050dfa91", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "Narrative styles and successful movies in related genres highlight the need for their project.", "position": 3, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e29f-7298-83f4-f399e710dc49", "docSlug": "23480e67a083cbde563694d24fd9cdc8", "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides", "authorId": "akt-pictures", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/14", "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49", "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 12, "beatId": "a7c7c48d-6147-4b5b-a88f-84cd050dfa91", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "Narrative styles and successful movies in related genres highlight the need for their project.", "position": 3, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e29f-7298-83f4-f399e710dc49", "docSlug": "23480e67a083cbde563694d24fd9cdc8", "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides", "authorId": "akt-pictures", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/15", "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49", "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 16, "from": 15, "beatId": "65ba646a-c3d7-484c-a696-291af6d4c0a6", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The production timeline offers a sense of progression and nearing completion.", "position": 4, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e29f-7298-83f4-f399e710dc49", "docSlug": "23480e67a083cbde563694d24fd9cdc8", "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides", "authorId": "akt-pictures", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "timeline", "function": "plan_implementation", "notes": "The timeline uses a diagonal layout with numbered steps.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/16", "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49", "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 16, "from": 15, "beatId": "65ba646a-c3d7-484c-a696-291af6d4c0a6", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The production timeline offers a sense of progression and nearing completion.", "position": 4, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e29f-7298-83f4-f399e710dc49", "docSlug": "23480e67a083cbde563694d24fd9cdc8", "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides", "authorId": "akt-pictures", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "closing_ask", "function": "state_next_steps", "notes": "The slide features the project title 'when I was a human' and a stylized graphic of a person and a dog shadow.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/17", "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49", "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 17, "from": 17, "beatId": "bc7b36d6-1de7-40f6-b9df-67063f2b1759", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The closing ask prompts action from the investors.", "position": 5, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/4SGQR6LqaMYx9lmNosII2IL4r74MTSKu5uyFcFWKfiA/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jNWVkNjBjNGNjODVhMDk0ZGJhZTJmYTEzY2IyNmEzNC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/1", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/ozrFYpR23ySjHPbVUKULzPdzzIz9qD6yuNpQLUxpGKs/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jNWVkNjBjNGNjODVhMDk0ZGJhZTJmYTEzY2IyNmEzNC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/_QR5pTvshvOA8iSYsmPlNgeg78nGCopNLw0LjHyTLbI/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jNWVkNjBjNGNjODVhMDk0ZGJhZTJmYTEzY2IyNmEzNC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/QNC8HVEToQt97BnYFGzQ-IBoFbLNHuN1zhYBg_hsWjw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jNWVkNjBjNGNjODVhMDk0ZGJhZTJmYTEzY2IyNmEzNC9wMDAxLnBuZw" }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/2", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/3", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/4", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a numbered list format to present five key highlights about the company's spin-off status, cytokine portfolio, and specific drug program progress.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/5", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style chart to map drug development stages across different indications.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/6", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-6", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "team_bio", "function": "introduce_nominees", "notes": "The slide lists names, titles, and previous company affiliations for both the Board and Management Team.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/7", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-7", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "problem_statement", "function": "frame_problem", "notes": "The diagram illustrates the interaction between T cells, tumor cells, and cytokines (IL-2, IL-12, IL-18) and the mechanism of checkpoint inhibitors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/8", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-8", "loopMatches": [ { "to": 9, "from": 8, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "b9e35abb-b37b-4734-a4e7-f370e28be28e", "evidence": "Slides 8-9 imply that current therapies have limitations and that Mural Oncology's solutions are needed.", "position": 0, "objective": "What are the consequences of not addressing the limitations of current cytokine therapies?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 8, "beatId": "3ac1c689-f5a4-4697-9836-72c6ac79bd59", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slides 8-9 discuss the role of cytokines in immuno-oncology and their limitations.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "key_messages", "function": "present_framework", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/9", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-9", "loopMatches": [ { "to": 9, "from": 8, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "b9e35abb-b37b-4734-a4e7-f370e28be28e", "evidence": "Slides 8-9 imply that current therapies have limitations and that Mural Oncology's solutions are needed.", "position": 0, "objective": "What are the consequences of not addressing the limitations of current cytokine therapies?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 8, "beatId": "3ac1c689-f5a4-4697-9836-72c6ac79bd59", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slides 8-9 discuss the role of cytokines in immuno-oncology and their limitations.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "comparison_table", "function": "present_solution", "notes": "The slide uses a problem-solution framework to justify the engineering approach for each therapeutic program.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/10", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-10", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/11", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "roadmap", "function": "present_framework", "notes": "Uses a vertical process flow diagram to represent development stage gates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/12", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 12, "beatId": "59c25a5c-9ce0-4688-9ac5-7b20dd5595fc", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 12-20 present Nemvaleukin alfa as a solution, including its development approach and clinical results.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "comparison_table", "function": "compare_peers", "notes": "Uses a before-after-framing style comparison to illustrate the mechanism of action differentiation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/13", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 12, "beatId": "59c25a5c-9ce0-4688-9ac5-7b20dd5595fc", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 12-20 present Nemvaleukin alfa as a solution, including its development approach and clinical results.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "appendix_data", "function": "analyze_data", "notes": "The chart displays longitudinal data for three cell types over 35 days, highlighting the differential pharmacodynamic response.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/14", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 12, "beatId": "59c25a5c-9ce0-4688-9ac5-7b20dd5595fc", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 12-20 present Nemvaleukin alfa as a solution, including its development approach and clinical results.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "comparison_table", "function": "present_framework", "notes": "The table uses a structured approach to categorize clinical trials into Foundational, Alternative Dosing, and Registrational enabling.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/15", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 12, "beatId": "59c25a5c-9ce0-4688-9ac5-7b20dd5595fc", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 12-20 present Nemvaleukin alfa as a solution, including its development approach and clinical results.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide uses a process flow diagram to illustrate the progression of the clinical trial cohorts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/16", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 12, "beatId": "59c25a5c-9ce0-4688-9ac5-7b20dd5595fc", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 12-20 present Nemvaleukin alfa as a solution, including its development approach and clinical results.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide presents clinical trial safety data (ARTISTRY-1) comparing monotherapy and combination therapy cohorts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/17", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 12, "beatId": "59c25a5c-9ce0-4688-9ac5-7b20dd5595fc", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 12-20 present Nemvaleukin alfa as a solution, including its development approach and clinical results.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a human body diagram to map clinical responses (CR, PR, uPR) by tumor type and treatment regimen.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/18", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 12, "beatId": "59c25a5c-9ce0-4688-9ac5-7b20dd5595fc", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 12-20 present Nemvaleukin alfa as a solution, including its development approach and clinical results.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes a swimmer plot (onco-plot) and a summary table of best overall response (BOR) metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/19", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 12, "beatId": "59c25a5c-9ce0-4688-9ac5-7b20dd5595fc", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 12-20 present Nemvaleukin alfa as a solution, including its development approach and clinical results.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "before_after", "function": "illustrate_case", "notes": "The slide uses a timeline to track treatment milestones and CT scans to show tumor reduction from baseline to complete response.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/20", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-20", "loopMatches": [ { "to": 21, "from": 20, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "ba81daf0-fae5-4421-90e6-9efd4d2dbee9", "evidence": "Slides 20-21 present clinical results showing improved treatment outcomes with Nemvaleukin alfa.", "position": 1, "objective": "How does Nemvaleukin alfa improve treatment outcomes?", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 20, "from": 12, "beatId": "59c25a5c-9ce0-4688-9ac5-7b20dd5595fc", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 12-20 present Nemvaleukin alfa as a solution, including its development approach and clinical results.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes a swimmer plot (left) and a summary table (right) with clinical trial metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/21", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-21", "loopMatches": [ { "to": 21, "from": 20, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "ba81daf0-fae5-4421-90e6-9efd4d2dbee9", "evidence": "Slides 20-21 present clinical results showing improved treatment outcomes with Nemvaleukin alfa.", "position": 1, "objective": "How does Nemvaleukin alfa improve treatment outcomes?", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "other", "function": "present_framework", "notes": "The slide outlines a clinical trial protocol with three distinct cohorts and specific dosing schedules.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/22", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "other", "function": "present_framework", "notes": "Clinical trial design diagram showing randomization, arms, dosing schedules, and endpoints.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/23", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a hub-and-spoke diagram for the mechanistic combinations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/24", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "other", "function": "present_solution", "notes": "The slide outlines the clinical strategy for optimizing nemvaleukin dosing, referencing specific clinical trials (ARTISTRY-3 and ARTISTRY-6).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/25", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/26", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "other", "function": "establish_context", "notes": "The slide uses a process diagram to show the IL-18 signaling cascade (IL-18 -> MYD88 -> IRAK -> NFkB -> IFNy) and a numbered list to detail its immunomodulatory functions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/27", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "Uses a combination of a scatter plot and biological mechanism diagrams to illustrate the inhibitory effect of IL-18BP.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/28", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "before_after", "function": "propose_solution", "notes": "Uses a before-after-bridge framework to illustrate the mechanism of action for the therapeutic candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/29", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "before_after", "function": "analyze_data", "notes": "Data shows that while WT IL-18 is inhibited by IL-18BP, the variants are resistant to this inhibition.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/30", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "The slide uses a diagram to illustrate the activation of immune cells (NKT, NK, CD4, CD8) by IL-12, leading to IFN-gamma production and subsequent downstream effects.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/31", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a process flow diagram to explain the therapeutic mechanism.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/32", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "propose_solution", "function": "present_solution", "notes": "Includes a bar chart showing dose-dependent PD response in a mouse model and a schematic of the split IL-12 mechanism.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/33", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-33", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/34", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-34", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes a footnote regarding patient enrollment for clinical milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/35", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-35", "loopMatches": [], "arcBeatMatches": [ { "to": 36, "from": 35, "beatId": "62a80895-2958-4f61-acc3-5b77095f6cea", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Slides 35-36 provide an overview of Mural Oncology's carve-out financials.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "executive_summary", "function": "summarize", "notes": "Uses a numbered list format to highlight key company facts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/36", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-36", "loopMatches": [], "arcBeatMatches": [ { "to": 36, "from": 35, "beatId": "62a80895-2958-4f61-acc3-5b77095f6cea", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Slides 35-36 provide an overview of Mural Oncology's carve-out financials.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e341-775b-a82c-decdaeb5c03e", "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34", "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides", "authorId": "alkermes", "authorName": "Mural Oncology", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "closing_ask", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/37", "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e", "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-37", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e430-7299-a96e-811e562ad763", "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6", "documentTitle": "Alkermes | Results Presentation Deck | 27 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/pROiI58Jz7Lzm2TfNS4KGdo_HBm63ExDOSSdJkWavg8/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZDFjYzZiZmQ1M2E5MmNlZjJkNDAzNDdjNWJjMjVlNi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/1", "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763", "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/7695__bwglmkktd5yPvhWI_h242az0h1oGcOCRL9liI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZDFjYzZiZmQ1M2E5MmNlZjJkNDAzNDdjNWJjMjVlNi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/JkZVVzsofV7l8OqdRnnkdIH_CtnVDYz8hn8cxha7EVQ/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZDFjYzZiZmQ1M2E5MmNlZjJkNDAzNDdjNWJjMjVlNi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/BRN3IMLsiFQ-Qumz-Y5PqLN0O9f5rR6UL1QrCwvpXHk/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZDFjYzZiZmQ1M2E5MmNlZjJkNDAzNDdjNWJjMjVlNi9wMDAxLnBuZw" }, { "docId": "019de075-e430-7299-a96e-811e562ad763", "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6", "documentTitle": "Alkermes | Results Presentation Deck | 27 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/2", "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763", "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e430-7299-a96e-811e562ad763", "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6", "documentTitle": "Alkermes | Results Presentation Deck | 27 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/3", "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763", "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 3, "beatId": "5792ec7a-9e33-4e5c-bbed-c0b82b590568", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The presentation starts with a review of Q3 2023 financial performance", "position": 0, "confidence": 0.7, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e430-7299-a96e-811e562ad763", "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6", "documentTitle": "Alkermes | Results Presentation Deck | 27 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide highlights significant growth in revenue and net income metrics year-over-year.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/4", "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763", "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 3, "beatId": "5792ec7a-9e33-4e5c-bbed-c0b82b590568", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The presentation starts with a review of Q3 2023 financial performance", "position": 0, "confidence": 0.7, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e430-7299-a96e-811e562ad763", "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6", "documentTitle": "Alkermes | Results Presentation Deck | 27 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes a blue box highlight around the Q3'23 column.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/5", "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763", "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e430-7299-a96e-811e562ad763", "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6", "documentTitle": "Alkermes | Results Presentation Deck | 27 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes both GAAP and non-GAAP projections, plus specific product revenue breakdowns.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/6", "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763", "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-6", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e430-7299-a96e-811e562ad763", "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6", "documentTitle": "Alkermes | Results Presentation Deck | 27 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/7", "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763", "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 7, "beatId": "a4749b6e-fdc8-41ea-a6b7-63976b98f45f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The commercial review section highlights topline growth and diversification", "position": 1, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e430-7299-a96e-811e562ad763", "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6", "documentTitle": "Alkermes | Results Presentation Deck | 27 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart illustrates the revenue contribution of four specific products (VIVITROL, ARISTADA, VUMERITY, LYBALVI) over time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/8", "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763", "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 7, "beatId": "a4749b6e-fdc8-41ea-a6b7-63976b98f45f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The commercial review section highlights topline growth and diversification", "position": 1, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e430-7299-a96e-811e562ad763", "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6", "documentTitle": "Alkermes | Results Presentation Deck | 27 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes a disclaimer regarding the forward-looking nature of the expectations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/9", "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763", "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 7, "beatId": "a4749b6e-fdc8-41ea-a6b7-63976b98f45f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The commercial review section highlights topline growth and diversification", "position": 1, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e430-7299-a96e-811e562ad763", "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6", "documentTitle": "Alkermes | Results Presentation Deck | 27 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart tracks TRx (Total Prescriptions) over 101 weeks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/10", "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763", "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 7, "beatId": "a4749b6e-fdc8-41ea-a6b7-63976b98f45f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The commercial review section highlights topline growth and diversification", "position": 1, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e430-7299-a96e-811e562ad763", "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6", "documentTitle": "Alkermes | Results Presentation Deck | 27 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "kpi_overview", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/11", "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763", "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 7, "beatId": "a4749b6e-fdc8-41ea-a6b7-63976b98f45f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The commercial review section highlights topline growth and diversification", "position": 1, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }